How much funding has Noema Pharma raised?

Noema Pharma has raised $318.0M in total funding, most recently a Extension Round.

Who are Noema Pharma's investors?

Noema Pharma's investors include Sofinnova Partners, EQT AB, Forbion Capital Partners, Jeito Capital, Polaris Partners, UPMC Enterprises.

When was Noema Pharma founded?

Noema Pharma was founded in 2019.

Where is Noema Pharma headquartered?

Noema Pharma is headquartered in Basel, Switzerland.

What industry is Noema Pharma in?

Noema Pharma operates in Biotech.

How many employees does Noema Pharma have?

Noema Pharma has 11-50 employees.

Noema Pharma

BEYOND SYMPTOM CONTROL

Basel, Switzerland · Founded 2019 · $318.0M raised

Biotech

Headquarters: Basel
Employees: 11–50
Founded: 2019
Business Model: B2B

Website: noemapharma.com
Total Funding: $318.0M
Last Round: $147.0M Extension RoundDec 2024
Rounds: 4

About

Noema Pharma is a clinical-stage biotech company advancing a late-stage portfolio of oral small molecule therapeutics with well-characterized mechanisms for people living with neurological and related disorders. Founded in 2019 with a seed investment from Sofinnova Partners and four clinical-stage assets in-licensed from Roche, the company pursues both orphan and larger CNS indications — including vasomotor symptoms, Tourette syndrome, and other debilitating neurological conditions — for which there are significant unmet medical needs and compelling scientific rationales for superior clinical benefit.

Summary

Noema Pharma is a Biotech company based in Basel, Switzerland, founded in 2019. It has raised $318.0M in total across 4 rounds, most recently a $147.0M Extension Round round in Dec 2024. Investors include Sofinnova Partners, EQT AB and Forbion Capital Partners.